MicroTech Medical (Hangzhou) Co., Ltd. Stock

Equities

2235

CNE100004QN6

Medical Equipment, Supplies & Distribution

Market Closed - Hong Kong S.E. 04:08:20 2024-04-26 EDT 5-day change 1st Jan Change
4.05 HKD +1.25% Intraday chart for MicroTech Medical (Hangzhou) Co., Ltd. +1.25% -36.72%

Financials

Sales 2023 253M 34.95M 274M 47.78M Sales 2024 * 366M 50.49M 395M 69.03M Capitalization 1.58B 218M 1.71B 298M
Net income 2023 -125M -17.25M -135M -23.58M Net income 2024 * -83M -11.45M -89.67M -15.66M EV / Sales 2023 2.26 x
Net cash position 2023 1.89B 260M 2.04B 356M Net cash position 2024 * 1.68B 232M 1.82B 317M EV / Sales 2024 * -0.28 x
P/E ratio 2023
-20.1 x
P/E ratio 2024 *
-18.7 x
Employees 760
Yield 2023 *
-
Yield 2024 *
-
Free-Float 26.61%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.25%
1 week+1.25%
Current month-3.11%
1 month-1.46%
3 months-5.81%
6 months+1.50%
Current year-36.72%
More quotes
1 week
4.00
Extreme 4
4.10
1 month
3.88
Extreme 3.88
4.55
Current year
3.76
Extreme 3.76
6.28
1 year
3.40
Extreme 3.4
7.01
3 years
3.40
Extreme 3.4
31.70
5 years
3.40
Extreme 3.4
31.70
10 years
3.40
Extreme 3.4
31.70
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 10-12-31
Chief Tech/Sci/R&D Officer 54 11-02-28
Chief Administrative Officer 41 13-11-30
Members of the board TitleAgeSince
Director/Board Member 43 20-09-30
Director/Board Member 56 21-04-20
Chief Executive Officer 54 10-12-31
More insiders
Date Price Change Volume
24-04-26 4.05 +1.25% 43,700
24-04-25 4 -0.50% 22,400
24-04-24 4.02 -0.50% 12,300
24-04-23 4.04 +1.00% 26,400
24-04-22 4 0.00% 26,800

Delayed Quote Hong Kong S.E., April 26, 2024 at 04:08 am

More quotes
MicroTech Medical Hangzhou Co Ltd is a China-based company that mainly engaged in research, production and commercialization of diabetes treatment and diabetes monitoring. The Company's products such as applicator insulin pump system (Equil), blood glucose monitoring system and continuous blood glucose monitoring system (AiDEX G7) have been commercialized. The Company's products, such as artificial pancreas, are in the process of research and development. The Company's products are sold to overseas markets such as the United States and the European Union.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
1
Last Close Price
3.749 CNY
Average target price
5.266 CNY
Spread / Average Target
+40.47%
Consensus